2001
DOI: 10.1183/09031936.01.17101570
|View full text |Cite
|
Sign up to set email alerts
|

Systemic bioavailability of inhaled steroids: the importance of appropriate and comparable methodology

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
9
0

Year Published

2001
2001
2014
2014

Publication Types

Select...
8

Relationship

1
7

Authors

Journals

citations
Cited by 13 publications
(9 citation statements)
references
References 6 publications
0
9
0
Order By: Relevance
“…Although initial PK studies suggested that the bioavailability of MF was ,1% [64], its systemic activity may be higher, potentially due to the presence of a number of active metabolites that are usually not detected [20,[69][70][71]. Therefore, the clinical relevance of the PK and PD characteristics of MF are still not clear.…”
Section: Modern and Emerging Inhaled Corticosteroidsmentioning
confidence: 99%
“…Although initial PK studies suggested that the bioavailability of MF was ,1% [64], its systemic activity may be higher, potentially due to the presence of a number of active metabolites that are usually not detected [20,[69][70][71]. Therefore, the clinical relevance of the PK and PD characteristics of MF are still not clear.…”
Section: Modern and Emerging Inhaled Corticosteroidsmentioning
confidence: 99%
“…5 However, the validity of the conclusion has been questioned. 6,7 The relative receptor affinity (RRA) of MF has been determined by competition assays with transfected COS-1 cells. 8 The relative affinity to the recombinant glucocorticoid receptor was calculated to be 1235, with a binding affinity of dexamethasone defined as 100.…”
Section: Introductionmentioning
confidence: 99%
“…Affrime et al assessed the pharmacokinetics of MF using a LC-MS-MS method with a lower limit of quantification of 50 pg/ml [8]. Because of insufficient sensitivity of the assay, concerns were expressed that a more sensitive assay is needed to adequately describe the pharmacokinetics of this drug after inhalation [9,10]. This paper presents a specific and sensitive atmospheric pressure chemical ionization (APCI) based LC-MS-MS assay using a multiple reaction monitoring technique suitable to quantify MF with sufficient sensitivity in human plasma after oral inhalation of therapeutic doses.…”
Section: Introductionmentioning
confidence: 99%